D-Kimia develops novel diagnostic solutions to detect a broad range of diseases by targeting the nucleic acid signature of the disease. Founded by Hassan Azzazy and Karim Hussein in 2013, D-Kimia is backed by investors that include American University in Cairo and is headquartered in New York.
FOUNDED:
2013
INDUSTRY:
Biotechnology, Health Care, Medical
FOUNDERS:
Hassan Azzazy, Karim Hussein
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
